GlassScriptPhysician profile
Christos Kasapis
NPI 1841318003
$10,965.98
in general payments reported to CMS, 2019-2025
39 companies · $1,679 in 2025
The $1,679 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,601 · 2020: $1,211 · 2021: $1,329 · 2022: $2,449 · 2023: $1,217 · 2024: $1,479 · 2025: $1,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,375.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,089.32 | 2021-2025 | Symplicity G3, Hawkone, Onyx Frontier |
| Abiomed | $1,630.32 | 2019-2025 | Impella |
| Abbott Laboratories | $1,285.17 | 2019-2025 | Gallant, Confirm Rx, Jot Dx |
| Shockwave Medical, INC | $1,186.84 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $1,067.26 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $620.61 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $342.20 | 2021-2025 | Verquvo |
| Endologix LLC | $244.64 | 2024 | Torus Stent Graft System, Endocross Device |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.82 | 2019-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $196.44 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $168.69 | 2019-2023 | Synergy, Watchman Access System |
| Medtronic Vascular, INC. | $165.33 | 2019-2020 | |
| Chiesi USA, INC. | $162.48 | 2020-2022 | |
| Cardiovascular Systems INC. | $160.06 | 2019-2023 | Diamondback Coronary |
| Pfizer INC. | $154.66 | 2019-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $150.00 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $148.98 | 2019 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| Edwards Lifesciences Corporation | $100.18 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $88.93 | 2021-2024 | Farxiga, Brilinta |
| Astellas Pharma US INC | $82.55 | 2019-2022 | |
| Ge Healthcare | $79.04 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $67.56 | 2019-2023 | |
| Amgen INC. | $56.24 | 2019-2022 | |
| Terumo Medical Corporation | $53.33 | 2022-2023 | Glidewire, Navicross |
| Bayer Healthcare Pharmaceuticals INC. | $53.00 | 2025 | |
| Philips North America LLC | $37.86 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Bard Peripheral Vascular, INC. | $37.36 | 2024 | Rotarexs 6 F X 135 Cm |
| Medela LLC | $24.93 | 2020 | |
| Impulse Dynamics (USA) INC. | $19.22 | 2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $17.94 | 2023 | Onpattro |
| Inspire Medical Systems, INC. | $17.77 | 2025 | Inspire |
| Surmodics, INC. | $17.67 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Pounce Thrombectomy |
| Angiodynamics, INC. | $16.71 | 2023 | Auryon Laser System 100-120 Vac |
| Regeneron Healthcare Solutions, INC. | $14.80 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.43 | 2025 | Assure Wcd |
| Lemaitre Vascular, INC. | $13.92 | 2019 | |
| Glaxosmithkline, LLC. | $13.59 | 2025 | Shingrix, Arexvy |
| Vifor Pharma, INC. | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christos Kasapis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.